Authors:
RUIZ L
NIJHUIS M
BOUCHER C
PUIG T
BONJOCH A
MARTINEZPICADO J
MARFIL S
DEJONG D
BURGER D
ARNO A
BALAGUE M
CLOTET B
Citation: L. Ruiz et al., EFFICACY OF ADDING INDINAVIR TO PREVIOUS REVERSE-TRANSCRIPTASE NUCLEOSIDE ANALOGS IN RELATION TO GENOTYPIC AND PHENOTYPIC RESISTANCE DEVELOPMENT IN ADVANCED HIV-1-INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 19(1), 1998, pp. 19-28
Authors:
WOUT ABVT
RAN LJ
NIJHUIS M
TIJNAGEL JMGH
DEGROOT T
VANLEEUWEN R
BOUCHER CAB
SCHUITEMAKER H
SCHUURMAN R
Citation: Abvt. Wout et al., EFFICIENT INHIBITION OF BOTH SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING WILD-TYPE HIV-1 BY LAMIVUDINE IN-VIVO, AIDS, 12(10), 1998, pp. 1169-1176
Authors:
NIJHUIS M
BOUCHER CAB
SCHIPPER P
LEITNER T
SCHUURMAN R
ALBERT J
Citation: M. Nijhuis et al., STOCHASTIC-PROCESSES STRONGLY INFLUENCE HIV-1 EVOLUTION DURING SUBOPTIMAL PROTEASE-INHIBITOR THERAPY, Proceedings of the National Academy of Sciences of the United Statesof America, 95(24), 1998, pp. 14441-14446
Authors:
NIJHUIS M
SCHUURMAN R
DEJONG D
VANLEEUWEN R
LANGE J
DANNER S
KEULEN W
DEGROOT T
BOUCHER CAB
Citation: M. Nijhuis et al., LAMIVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS (184V) REQUIRE MULTIPLE AMINO-ACID CHANGES TO BECOME CO-RESISTANT TO ZIDOVUDINE IN-VIVO, The Journal of infectious diseases, 176(2), 1997, pp. 398-405
Authors:
BACK NKT
NIJHUIS M
KEULEN W
BOUCHER CAB
ESSINK BBO
VANKUILENBURG ABP
VANGENNIP AH
BERKHOUT B
Citation: Nkt. Back et al., REDUCED REPLICATION OF 3TC-RESISTANT HIV-1 VARIANTS IN PRIMARY-CELLS DUE TO A PROCESSIVITY DEFECT OF THE REVERSE-TRANSCRIPTASE ENZYME, EMBO journal, 15(15), 1996, pp. 4040-4049
Authors:
BOUCHER CAB
KEULEN W
VANBOMMEL T
NIJHUIS M
DEJONG D
DEJONG MD
SCHIPPER P
BACK NKT
Citation: Cab. Boucher et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DRUG SUSCEPTIBILITY DETERMINATIONBY USING RECOMBINANT VIRUSES GENERATED FROM PATIENT SERA TESTED IN A CELL-KILLING ASSAY, Antimicrobial agents and chemotherapy, 40(10), 1996, pp. 2404-2409
Authors:
SCHUURMAN R
VANLEEUWEN R
NIJHUIS M
KWOK S
DEJONG D
BOUCHER C
Citation: R. Schuurman et al., TURNOVER OF SYNCYTIUM-INDUCING AND NON-SYNCYTIUM-INDUCING HIV-1 IN PATIENTS TREATED WITH 3TC, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 39-39
Authors:
NIJHUIS M
DEJONG D
VANLEEUWEN R
DEGROOT T
KEULEN W
SCHUURMAN R
BOUCHER C
Citation: M. Nijhuis et al., THE RISE IN HIV-1 RNA LOAD DURING 3TC AZT COMBINATION THERAPY IS ASSOCIATED WITH THE SELECTION OF VIRUSES RESISTANT TO BOTH 3TC AND AZT/, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 52-52
Authors:
BACK N
KEULEN W
NIJHUIS M
VANBOMMEL T
DEJONG D
DEJONG M
SCHUURMAN R
BOUCHER C
Citation: N. Back et al., A CONVENIENT APPROACH TO DETERMINING THE DRUG SUSCEPTIBILITY FROM SERUM HIV-1 RNA, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 88-88
Citation: M. Nijhuis et al., SENSITIVE PROCEDURE FOR THE AMPLIFICATION OF HIV-1 RNA USING A COMBINED REVERSE-TRANSCRIPTION AND AMPLIFICATION REACTION, BioTechniques, 19(2), 1995, pp. 178
Authors:
SCHUURMAN R
NIJHUIS M
VANLEEUWEN R
SCHIPPER P
DEJONG D
COLLIS P
DANNER SA
MULDER J
LOVEDAY C
CHRISTOPHERSON C
KWOK S
SNINSKY J
BOUCHER CAB
Citation: R. Schuurman et al., RAPID CHANGES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA LOAD AND APPEARANCE OF DRUG-RESISTANT VIRUS POPULATIONS IN PERSONS TREATED WITH LAMIVUDINE (3TC), The Journal of infectious diseases, 171(6), 1995, pp. 1411-1419
Authors:
SIEZEN RJ
BRUINENBERG PG
VOS P
VANALENBOERRIGTER I
NIJHUIS M
ALTING AC
EXTERKATE FA
DEVOS WM
Citation: Rj. Siezen et al., ENGINEERING OF THE SUBSTRATE-BINDING REGION OF THE SUBTILISIN-LIKE, CELL-ENVELOPE PROTEINASE OF LACTOCOCCUS-LACTIS, Protein engineering, 6(8), 1993, pp. 927-937
Citation: G. Simons et al., INTEGRATION AND GENE REPLACEMENT IN THE LACTOCOCCUS-LACTIS LAC OPERON- INDUCTION OF A CRYPTIC PHOSPHO-BETA-GLUCOSIDASE IN LACG-DEFICIENT STRAINS, Journal of bacteriology, 175(16), 1993, pp. 5168-5175